Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Mdc Gonzalez Medina"'
Autor:
A Rodriguez Delgado, S Belda Rustarazo, C García Fernández, Mdc Gonzalez Medina, P Nieto Gómez, I Casas Hidalgo, C Gómez Peña
Publikováno v:
Other hospital pharmacy topics.
Background In different clinical studies, the use of botulinum toxin has shown a reduction in health spending, reducing the number of drugs used for patients and decreasing the number of doctor visits and the frequency of episodes. Purpose To analyse
Autor:
C Gómez-Peña, C García Fernández, M Valle Corpas, R Morón Romero, J Cabeza-Barrera, Mdc Gonzalez Medina, CL Dávila Fajardo, X Díaz-Villamarín, I Casas Hidalgo, Clara Marin
Publikováno v:
European Journal of Hospital Pharmacy. 23:A30.2-A31
Background Fampridine has been approved for improvement in walking capacity (WC) in multiple sclerosis adult patients with Expanded Disability Status Scale (EDSS) score of 4–7. Purpose To evaluate the effectiveness of fampridine in WC in MS patient
Autor:
R Morón Romero, J Cabeza Barrera, Mdc Gonzalez Medina, C García Fernández, C Gómez Peña, I Casas Hidalgo, M Valle Corpas
Publikováno v:
European Journal of Hospital Pharmacy. 23:A84.2-A85
Background Medication reconciliation (MR) is known to minimise medicine errors and reduce morbidity in hospitalised patients. This process aims to identify and solve unintended medicine discrepancies, defined as differences between the home treatment
Autor:
R Morón Romero, LJ Martinez, CL Dávila Fajardo, X Diaz Villamarin, M Valle Corpas, D Blanquez Martinez, MJ Soto Pino, J Cabeza Barrera, E Raya Alvarez, Mdc Gonzalez Medina
Publikováno v:
European Journal of Hospital Pharmacy. 23:A142.1-A142
Background Tocilizumab (TCZ) is a humanised monoclonal antibody inhibitor of interleukin 6 receptor, indicated in combination with methotrexate in the treatment of rheumatoid arthritis (RA) in patients with inadequate response or intolerance to prior
Autor:
A Rodriguez Delgado, C Gómez Peña, A Valle Ruiz de la Guardia, R Morón Romero, M Valle Corpas, A Caballero Romero, Mdc Gonzalez Medina, J Cabeza Barrera
Publikováno v:
European Journal of Hospital Pharmacy. 23:A212.1-A212
Background Oncology patients often have swallowing problems or dysphagia. Dysphagia is a frequent syndrome in patients with tumours involving the CNS, head and neck, and upper aerodigestive tract. This can be the initial symptom or related to the onc
Autor:
R Morón Romero, M Valle Corpas, I Casas Hidalgo, C García Fernández, Mdc Gonzalez Medina, S Belda Rustarazo, C Gómez Peña, S Ruiz Fuentes
Publikováno v:
European Journal of Hospital Pharmacy. 23:A88.2-A89
Background Administration of immunosuppressive drugs can cause reactivation of hepatitis B virus (HBV), both asymptomatic and fulminant hepatitis. In July 2014, the Spanish Agency for Medicines and Health Products (AEMPS) published a press release in
Autor:
A Caballero Romero, C Gómez Peña, R Morón Romero, C García Fernández, Mdc Gonzalez Medina, M Valle Corpas, S Ruiz Fuentes, D Blanquez Martinez, I Casas Hidalgo
Publikováno v:
European Journal of Hospital Pharmacy. 22:A15.1-A15
Background Hormone treatment based on analogues of gonadotropin releasing hormone (GnRH) with antiandrogens is the first-line treatment for prostate cancer. This treatment produces a PSA reduction, improvement of symptoms and tumour regression. When